Chronic obstructive pulmonary disease in China: the potential role of indacaterol

Por Gao, Jinming, Prasad, Niyati
Publicado em 2013

Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day

Por Pedersen, Søren E, Prasad, Niyati, Goehring, Udo-Michael, Andersson, Henrik, Postma, Dirkje S
Publicado no J Asthma Allergy (2017)

Efficacy and safety of indacaterol 150 <it>μ</it>g once-daily in COPD: a double-blind, randomised, 12-week study

Por Piggott Simon, Jack Damon, Prasad Niyati, Siler Thomas, Feldman Gregory, Owen Roger, Higgins Mark, Kramer Benjamin
Publicado em 2010-03-01

Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study

Por Feldman, Gregory, Siler, Thomas, Prasad, Niyati, Jack, Damon, Piggott, Simon, Owen, Roger, Higgins, Mark, Kramer, Benjamin
Publicado em 2010